Ada C Stefanescu Schmidt1, Aimee Armstrong2, Kevin F Kennedy3, David Nykanen4, Jamil Aboulhosn5, Ami B Bhatt1. 1. Heart Center, Massachusetts General Hospital, 55 Fruit Street, Yawkey 5B, Boston, MA, 02114, USA. 2. Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA. 3. Saint Luke's Hospital, 4401 Wornall Road, Kansas City, MO 64111, USA. 4. Heart Center, Arnold Palmer Hospital for Children, 1222 South Orange Avenue, Orlando, FL 32806, USA. 5. Ahmanson/UCLA Adult Congenital Heart Disease Center, 100 Medical Plaza, Los Angeles, CA 90095, USA.
Abstract
AIMS: We sought to identify factors associated with major adverse events (MAE) after cardiac catheterization in adolescents and adults with congenital heart disease (CHD), and create the first model to individualize risk discussions in this growing population. METHODS AND RESULTS: Improving Pediatric and Adult Congenital Treatment (IMPACT), a National Cardiovascular Data Registry, contains congenital catheterization data from over 87 hospitals in the United States. Demographics, pre-procedure, and procedural variables were collected for patients over age 10. Multivariable logistic regression was used to identify significant predictors of MAE, a composite of death, urgent surgery or procedure due to a catheterization complication, transfusion, embolic stroke, tamponade, extracorporeal membrane oxygenation or ventricular assist device placement, and device embolization, malposition or thrombosis requiring surgical intervention. A risk score was built based on the effect sizes of each predictor and validated in a split sample. A MAE occurred in 686 (2.5%) of the 27 293 index procedures meeting inclusion criteria. The independent multivariate predictors of MAE were older age, pre-procedural anticoagulation use, renal disease, lower haemoglobin, lower oxygen saturation, non-elective procedure, higher index procedure risk and having had no prior cardiac procedures. Being underweight or overweight had borderline significance and was added to the model. The C-statistic for the model was robust at 0.787 in the derivation and 0.773 in the validation cohort. CONCLUSION: The factors predicting adverse events after cardiac catheterization in adolescents and adults with CHD are different than in the general population. Validation of this model in other national or multi-institutional datasets is the next step. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: We sought to identify factors associated with major adverse events (MAE) after cardiac catheterization in adolescents and adults with congenital heart disease (CHD), and create the first model to individualize risk discussions in this growing population. METHODS AND RESULTS: Improving Pediatric and Adult Congenital Treatment (IMPACT), a National Cardiovascular Data Registry, contains congenital catheterization data from over 87 hospitals in the United States. Demographics, pre-procedure, and procedural variables were collected for patients over age 10. Multivariable logistic regression was used to identify significant predictors of MAE, a composite of death, urgent surgery or procedure due to a catheterization complication, transfusion, embolic stroke, tamponade, extracorporeal membrane oxygenation or ventricular assist device placement, and device embolization, malposition or thrombosis requiring surgical intervention. A risk score was built based on the effect sizes of each predictor and validated in a split sample. A MAE occurred in 686 (2.5%) of the 27 293 index procedures meeting inclusion criteria. The independent multivariate predictors of MAE were older age, pre-procedural anticoagulation use, renal disease, lower haemoglobin, lower oxygen saturation, non-elective procedure, higher index procedure risk and having had no prior cardiac procedures. Being underweight or overweight had borderline significance and was added to the model. The C-statistic for the model was robust at 0.787 in the derivation and 0.773 in the validation cohort. CONCLUSION: The factors predicting adverse events after cardiac catheterization in adolescents and adults with CHD are different than in the general population. Validation of this model in other national or multi-institutional datasets is the next step. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Lisa Bergersen; Kimberlee Gauvreau; Susan R Foerster; Audrey C Marshall; Doff B McElhinney; Robert H Beekman; Russel Hirsch; Jacqueline Kreutzer; David Balzer; Julie Vincent; William E Hellenbrand; Ralf Holzer; John P Cheatham; John W Moore; Grant Burch; Laurie Armsby; James E Lock; Kathy J Jenkins Journal: JACC Cardiovasc Interv Date: 2011-09 Impact factor: 11.195
Authors: Ewout W Steyerberg; Gerard J J M Borsboom; Hans C van Houwelingen; Marinus J C Eijkemans; J Dik F Habbema Journal: Stat Med Date: 2004-08-30 Impact factor: 2.373
Authors: Helmut Baumgartner; Philipp Bonhoeffer; Natasja M S De Groot; Fokko de Haan; John Erik Deanfield; Nazzareno Galie; Michael A Gatzoulis; Christa Gohlke-Baerwolf; Harald Kaemmerer; Philip Kilner; Folkert Meijboom; Barbara J M Mulder; Erwin Oechslin; Jose M Oliver; Alain Serraf; Andras Szatmari; Erik Thaulow; Pascal R Vouhe; Edmond Walma Journal: Eur Heart J Date: 2010-08-27 Impact factor: 29.983
Authors: Ralf Holzer; Robert Beekman; Lee Benson; Lisa Bergersen; Natalie Jayaram; Kathy Jenkins; Kevin Kennedy; John Moore; Richard Ringel; Jonathan Rome; Robert Vincent; Gerard R Martin Journal: Cardiol Young Date: 2015-10-12 Impact factor: 1.093
Authors: Swati Garekar; Melissa M Paules; Surendranath V Reddy; Daniel R Turner; Sanjeev Sanjeev; Joshua Wynne; Michael L Epstein; Peter P Karpawich; Robert D Ross; Thomas J Forbes Journal: Catheter Cardiovasc Interv Date: 2005-11 Impact factor: 2.692
Authors: M Moscucci; E Kline-Rogers; D Share; M O'Donnell; A Maxwell-Eward; W L Meengs; P Kraft; A C DeFranco; J L Chambers; K Patel; J G McGinnity; K A Eagle Journal: Circulation Date: 2001-07-17 Impact factor: 29.690
Authors: John W Moore; Robert N Vincent; Robert H Beekman; Lee Benson; Lisa Bergersen; Ralf Holzer; Natalie Jayaram; Kathy Jenkins; Yan Li; Richard Ringel; Jonathan Rome; Gerard R Martin Journal: J Am Coll Cardiol Date: 2014-12-16 Impact factor: 24.094
Authors: David G Nykanen; Thomas J Forbes; Wei Du; Abhay A Divekar; Jaxk H Reeves; Donald J Hagler; Thomas E Fagan; Carlos A C Pedra; Gregory A Fleming; Danyal M Khan; Alexander J Javois; Daniel H Gruenstein; Shakeel A Qureshi; Phillip M Moore; David H Wax Journal: Catheter Cardiovasc Interv Date: 2015-11-03 Impact factor: 2.692
Authors: Winthrop D Piper; David J Malenka; Thomas J Ryan; Samuel J Shubrooks; Gerald T O'Connor; John F Robb; Karen L Farrell; Mary S Corliss; Michael J Hearne; Mirle A Kellett; Matthew W Watkins; William A Bradley; Bruce D Hettleman; Theodore M Silver; Paul D McGrath; John R O'Mears; David E Wennberg Journal: Am Heart J Date: 2003-06 Impact factor: 4.749
Authors: Santosh Kaipa; Christopher W Mastropietro; Hamza Bhai; Riad Lutfi; Matthew L Friedman; Mouhammad Yabrodi Journal: World J Cardiol Date: 2020-10-26